140 related articles for article (PubMed ID: 33067739)
1. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
2. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
[TBL] [Abstract][Full Text] [Related]
3. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
4. KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/β-catenin signaling.
Zhao R; Wang S; Liu J; Xu C; Zhang S; Shao Y; Duan X
J Bioenerg Biomembr; 2021 Feb; 53(1):85-96. PubMed ID: 33420975
[TBL] [Abstract][Full Text] [Related]
5. ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.
Saladi SV; Ross K; Karaayvaz M; Tata PR; Mou H; Rajagopal J; Ramaswamy S; Ellisen LW
Cancer Cell; 2017 Jan; 31(1):35-49. PubMed ID: 28041841
[TBL] [Abstract][Full Text] [Related]
6. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.
Ma L; Shan L
Exp Lung Res; 2021; 47(5):250-259. PubMed ID: 33896314
[No Abstract] [Full Text] [Related]
7. Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization.
Wu T; Wang G; Zeng X; Sun Z; Li S; Wang W; Yu B
Cell Cycle; 2021 Sep; 20(18):1799-1811. PubMed ID: 34437823
[TBL] [Abstract][Full Text] [Related]
8. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
9. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
[TBL] [Abstract][Full Text] [Related]
10. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
Kang R; Yao DF; Xu GZ; Zhou YH
Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 drives the growth of laryngeal squamous cell carcinoma via regulating YAP activity.
Zang Y; Li J; Wan B; Tai Y; Liu H; Li Q; Ji Y
Hum Cell; 2021 Nov; 34(6):1878-1887. PubMed ID: 34515990
[TBL] [Abstract][Full Text] [Related]
12. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
13. Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
Li J; Sun S; Chen W; Yuan K
Med Sci Monit; 2019 Jul; 25():5552-5560. PubMed ID: 31348766
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced transmembrane protein 1 (IFITM1) is essential for progression of laryngeal squamous cell carcinoma in an Osteopontin/NF-κB-dependent manner.
Yin Y; Yang K; Li J; Da P; Zhang Z; Qiu X
Cancer Biomark; 2020; 29(4):521-529. PubMed ID: 32865181
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC01638 contributes to laryngeal squamous cell cancer progression by modulating miR-523-5p/BATF3 axis.
Zhang H; Zhao X; Wang M; Ji W
Aging (Albany NY); 2021 Mar; 13(6):8611-8619. PubMed ID: 33714208
[TBL] [Abstract][Full Text] [Related]
16. Erchen decoction plus huiyanzhuyu decoction inhibits the cell cycle, migration and invasion and induces the apoptosis of laryngeal squamous cell carcinoma cells.
Zhou S; Luo Q; Tan X; Huang W; Feng X; Zhang T; Chen W; Yang C; Li Y
J Ethnopharmacol; 2020 Jun; 256():112638. PubMed ID: 32007633
[TBL] [Abstract][Full Text] [Related]
17. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
18. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
Sun W; Wang W; Lei J; Li H; Wu Y
Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma.
Wang X; Xu C; Wang S; Huang W; Liu Y; Zhang X; Li N; Gao Z; Wang F; Zhang N; Guan J; Yi H; Liu F
Clin Transl Oncol; 2021 Sep; 23(9):1942-1954. PubMed ID: 33826083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
